Prospective Observational Exploratory Clinical Study to Determine the Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict Gastrointestinal Radiation Toxicity Using Circulating Cell Free DNA Directly From Plasma
Recruiting
- Conditions
- Prostate Cancer
- Interventions
- Other: Collection of plasma samples
- First Posted Date
- 2020-10-08
- Last Posted Date
- 2023-09-07
- Lead Sponsor
- DiaCarta, Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT04580667
- Locations
- 🇺🇸
NY Cancer and Blood Specialists, Port Jefferson Station, New York, United States
🇺🇸University of Florida, Gainesville, FL, Gainesville, Florida, United States
🇺🇸UF Health Proton Therapy Institute, Jacksonville, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath